Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction
NCT05556044
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Acute Heart Failure
Interventions
DRUG:
Empagliflozin 10 MG
Sponsor
Chinese University of Hong Kong